Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18420099 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER);   Drug: Comparator: Placebo to ezetimibe/simvastatin;   Drug: Comparator: niacin (ER) tablet;   Drug: Comparator: ezetimibe (+) simvastatin;   Drug: Comparator: Placebo to Niacin (ER);   Drug: Comparator: ezetimibe/simvastatin and niacin (ER);   Drug: Comparator: ezetimibe and simvastatin;   Drug: Comparator: Placebo to niacin (ER)

Study has passed its completion date and status has not been verified in more than two years.